September 18 - Recurrence and the Rebound
Jan and I sat down on September 13th with Dr. Amy Dezern, head of the MDS (Myelodysplasia Syndrome) branch of Oncology at Johns Hopkins Medical Center. What Jan and I had suspected from the preliminary results of the flow cytometry and the bone marrow biopsy was confirmed by Dr. Dezern. There is a small recurrence of my MDS cells in the bone marrow. However, the news had some positive results as well. Let me explain. The chimerism test (a test to show what amount of the the donor and host) showed that Erika's cells were 94% of the sample and my bone marrow contribution (the host) was 6%. This means that the chimerism test from early June, which was 100% Erika cells had reduced down to 94%. The cytogenetic studies revealed that 19 had a karyotype of female (Erika) and 3 had a male karyotype (me). This means that Erika's cells continue to predominate. The other good news is that my white blood cell count has increased to 6100 with an absolute neut...